Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 18

    Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals appointed new CII President

    Shobana Kamineni, Executive Vice Chairperson, Apollo Hospitals appointed new CII President

    supriya kashyap kashyap2 May 2017 11:10 AM IST
    The Confederation of Indian Industry (CII) announced new office-bearers for the year 2017-18. Ms Shobana Kamineni, Executive Vice Chairperson, Apollo...
    FDA approves new combination treatment for acute myeloid leukemia

    FDA approves new combination treatment for acute myeloid leukemia

    supriya kashyap kashyap30 April 2017 10:15 AM IST
    The U.S. Food and Drug Administration approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid leukemia...
    Find how Healthcare IT fared in funding this year : Mercom Capital Group Report

    Find how Healthcare IT fared in funding this year : Mercom Capital Group Report

    supriya kashyap kashyap28 April 2017 10:21 AM IST
    New Delhi : Mercom Capital Group, llc, a global communications and research firm, released its report on funding and mergers and acquisitions...
    USFDA takes action against 14 companies for selling illegal cancer treatments

    USFDA takes action against 14 companies for selling illegal cancer treatments

    Ruby Khatun Khatun27 April 2017 10:35 AM IST
    The U.S. Food and Drug Administration posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that...
    Piramal Enterprises Partners with IPA to Educate Stakeholders on Responsible Self-Care

    Piramal Enterprises Partners with IPA to Educate Stakeholders on Responsible Self-Care

    supriya kashyap kashyap20 April 2017 11:40 AM IST
    Mumbai : Piramal Enterprises Consumer Products business has partnered with the Indian Pharmaceutical Association (IPA), to promote responsible...
    Medtronic Signs Definitive Agreement to sell Patient Monitoring,Recovery Division to Cardinal Health for $6.1 Billion

    Medtronic Signs Definitive Agreement to sell Patient Monitoring,Recovery Division to Cardinal Health for $6.1 Billion

    supriya kashyap kashyap20 April 2017 11:40 AM IST
    Dublin : Medtronic plc announced that it has entered into a definitive agreement with Cardinal Health Inc. to sell its Patient Care, Deep Vein...
    Sun Pharma Share Price Falls 3 Percent on 11 Observations from USFDA for Dadra Unit

    Sun Pharma Share Price Falls 3 Percent on 11 Observations from USFDA for Dadra Unit

    supriya kashyap kashyap19 April 2017 9:38 AM IST
    Sun Pharmaceutical Industries share price fell 3 percent. Investors turned cautious as sources told CNBC-TV18 that company's Dadra unit has received...
    Takeda enrols more Than 20,000 Children,Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate

    Takeda enrols more Than 20,000 Children,Adolescents in Global Phase 3 Trial of Dengue Vaccine Candidate

    supriya kashyap kashyap17 April 2017 11:48 AM IST
    Takeda Pharmaceutical Company Limited, announced that it has completed enrollment of 20,100 children and adolescents ages 4 through 16in its global,...
    US Healthtech Startup AkosMD Coming to India

    US Healthtech Startup AkosMD Coming to India

    supriya kashyap kashyap17 April 2017 11:48 AM IST
    AkosMD was started in the US to facilitate affordable and faster primary healthcare, a basic right which often is too expensive and takes long to...
    APAC Biotech gets Indian FDA Approval for Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN®

    APAC Biotech gets Indian FDA Approval for Autologous Dendritic Cell-based Immuno-oncology Product, APCEDEN®

    supriya kashyap kashyap16 April 2017 10:20 AM IST
    A first-of-its-kind Indian biotechnology company, APAC Biotech, was granted with a commercial license by Indian FDA (CDSCO - Central Drugs Standard...
    RMS regrow get FDA India approval for Cell Therapy Product

    RMS regrow get FDA India approval for Cell Therapy Product

    savita thakur thakur16 April 2017 9:14 AM IST
    Mumbai: The Ministry of Health, India and DCGI have granted Market Authorization for India’s First Cell Therapy Product of India that is Chondron® ACI...
    Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

    Philips receives FDA clearance to market Philips IntelliSite Pathology Solution for primary diagnostic use in the US

    supriya kashyap kashyap15 April 2017 9:40 AM IST
    Royal Philips, a global leader in health technology, announced it has received regulatory clearance (via De Novo classification) from the U.S. Food...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    German drug assessment body not convinced by Bayers cancer drug Vitrakvi

    German drug assessment body not convinced by Bayer's cancer drug Vitrakvi

    Government appoints 108 drug inspectors pan India; Details

    Government appoints 108 drug inspectors pan India; Details

    300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

    300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok